Sinocelltech Group Ltd

688520

Company Profile

  • Business description

    Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.

  • Contact

    Kechuang Seventh Street
    Beijing Economic and Technological Development Zone
    Room 307, Building 5, Courtyard 31
    Beijing100176
    CHN

    T: +86 1058628288

    http://www.sinocelltech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    2,277

Stocks News & Analysis

stocks

Unconventional wisdom: Are dividends the answers?

As investors toil in complexity the obvious solution may be the right one.
stocks

Netflix: A business that’s nearly flawless

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks

Trump’s US dollar assault is fuelling CBA’s rise

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,934.1045.30-0.50%
CAC 407,818.2832.15-0.41%
DAX 4024,295.9355.110.23%
Dow JONES (US)44,693.91316.38-0.70%
FTSE 1009,138.3776.880.85%
HKSE25,667.18129.110.51%
NASDAQ21,057.9637.940.18%
Nikkei 22541,701.94124.40-0.30%
NZX 50 Index12,829.6624.530.19%
S&P 5006,363.354.440.07%
S&P/ASX 2008,664.2045.20-0.52%
SSE Composite Index3,604.681.05-0.03%

Market Movers